We have some exciting news to share! The Motley Fool UK has now become an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. We’ll be introducing a new name and brand over the coming weeks — we're very excited to share it with you and embark on this new chapter together!

2 FTSE 100 stocks I’d buy to build wealth in the long run

After the market sell-off, I’m looking at cheap FTSE 100 stocks to help my portfolio grow over the long run and, if I’m lucky, retire early.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Mature people enjoying time together during road trip

Image source: Getty Images

The FTSE 100 hasn’t had a great month. In fact, it’s down around 5% over the last 30 days after a series of negative announcements triggered a global sell-off.

However, stock market volatility also provides an opportunity to buy. And even before the sell-off, I saw the FTSE 100 as a great place to find dividend-paying value stocks for my portfolio.

So here are two lead index stocks I’m looking to add to my portfolio to build wealth over the long run. Both are down in recent months, neither are paying anything special in terms of dividends, but I think they will perform well over the next three-to-five years.

Smith & Nephew

Smith & Nephew (LSE:SN) stock is trading near its year-low, but things are looking brighter for this medical device manufacturer. The stock fell 10% in June amid a global sell-off. But I think this represents a good chance to buy.

The firm is still reeling from the impact of Covid-19. The virus brought a halt to elective medical procedures and this still impacts the sector today. In 2020, Smith & Nephew saw pre-tax profits fall to $246m, from $743 in 2019. 

But cancellations are becoming less common and hospitals are increasingly adept at dealing with the virus and its impact. Profits doubled to $586m in 2021, despite record Covid hospitalisations in the UK and elsewhere in Europe.

The latest news has been positive too. In April, Smith & Nephew said Q1 revenue rose 5.9% year-on-year to $1.31bn. This was above analysts’ forecasts of $1.27bn. The firm also said emerging markets revenue was up 14.3%.

With performance not yet back to pre-pandemic levels, Smith & Nephew doesn’t offer the best dividend yield. At today’s price, it’s around 2.5%. But I’d expect to see that rise as operating conditions improve.

Burberry

Burberry (LSE:BRBY) is one of the most iconic brands around. But at the moment, outlook for the luxury fashion house is very dependent on the Chinese economy. With China imposing lockdowns every time authorities come across a cluster of Covid-19 cases, it doesn’t look too positive.

However, I think this has been factored into the share price already. The stock is down 25% over the past year with China wrestling with Covid-19 and other economic pressures, notably the property sector.

But this is also a highly profitable business with impressive margins. Currently, the firm has a price-to-earnings (P/E) ratio of 13.5. By comparison, luxury goods group Kering, which owns dozens of high-end brands, has a P/E ratio of around 20. While less diversified that the French conglomerate, Burberry certainly looks a lot cheaper.

The weakness of the British pound may also offset a near-term fall in sales.

But in the long run, I think Burberry is a brand that will continue to deliver. It has successfully transformed itself into a modern business that attracts customers from all age groups across the globe.

The dividend is a meagre 2.5% right now. But, like Smith & Nephew, I’d expect to see that rise as the operating environment improves.

James Fox owns shares in Smith & Nephew. The Motley Fool UK has recommended Burberry and Smith & Nephew. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Passive and Active: text from letters of the wooden alphabet on a green chalk board
Investing Articles

How am I targeting an annual passive income of £14,754 from just a £20,000 holding in this FTSE financial giant?

Investors chasing passive income may be missing a rare opportunity in this FTSE firm — a combination of stability and…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

Why is the Trainline share price falling when revenues are growing?

Today's results have sent the Trainline share price down sharply in early trading. But our writer thinks they offered reasons…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Are Greggs shares 50.3% undervalued?

Stephen Wright’s DCF analysis suggests Greggs' shares are trading at a 50.3% discount to their intrinsic value. But how plausible…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

Around £5 now, here’s why this FTSE banking giant looks a bargain buy anywhere below £12.67

This FTSE 100 stock is delivering stronger earnings and rising payouts, yet the market still prices it like a laggard,…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

Down 17% from February, do Barclays’ sub-£5 shares look a steal to me after its Q1 results?

Barclays shares have slipped, yet the valuation story is moving the other way. Is the market overlooking a rare chance…

Read more »

Man thinking about artificial intelligence investing algorithms
Investing Articles

Buy the dip on Palantir shares?

Despite incredible results, Palantir shares fell after the firm reported earnings. Is this what happens when a stock is priced…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

13% annual earnings growth forecast and 44% under ‘fair value! 1 FTSE 100 gem to buy today?

This FTSE 100 heavyweight keeps posting impressive growth, but its valuation hasn’t caught up yet -- is this now an…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

Down 8%, is Shell’s share price a steal now around £33?

With Shell’s share price lagging far behind its underlying value, could this be one of the FTSE 100’s most overlooked…

Read more »